Nanoparticulate alternatives for drug delivery

James H. Adair, Mylisa P. Parette, Erhan I. Altinoǧlu, Mark Kester

Research output: Contribution to journalArticle

149 Scopus citations

Abstract

The ability to apply nanomaterials as targeted delivery agents for drugs and other therapeutics holds promise for a wide variety of diseases, including many types of cancer. A nanodelivery vehicle must demonstrate in vivo efficacy, diminished or no toxicity, stability, improved pharmacokinetics, and controlled-release kinetics. In this issue, Lee et al.construct polymer nanobins that fulfill these requirements and demonstrate effective delivery of doxorubicin in vivo to breast cancer cells. This Perspective explores the outlook for these nanobins as well as other technologies in this field and the challenges that lie ahead.

Original languageEnglish (US)
Pages (from-to)4967-4970
Number of pages4
JournalACS nano
Volume4
Issue number9
DOIs
StatePublished - Sep 28 2010

All Science Journal Classification (ASJC) codes

  • Materials Science(all)
  • Engineering(all)
  • Physics and Astronomy(all)

Fingerprint Dive into the research topics of 'Nanoparticulate alternatives for drug delivery'. Together they form a unique fingerprint.

  • Cite this

    Adair, J. H., Parette, M. P., Altinoǧlu, E. I., & Kester, M. (2010). Nanoparticulate alternatives for drug delivery. ACS nano, 4(9), 4967-4970. https://doi.org/10.1021/nn102324e